LIZheng 1,2,3 , MIDeng-hai 1,2,3 , YANGKe-hu 1,2 , CAONong 1 , TIANJin-hui 2 , MABin 2 , BAIZheng-gang 2
  • 1. The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China;
  • 2. Evidence Based Medicine Center of Lanzhou University, Lanzhou 730000, China;
  • 3. The Second People's Hospital of Gansu Province, Lanzhou 730000, China;
MIDeng-hai, Email: mi.dh@163.com
Export PDF Favorites Scan Get Citation

Objective To systematically review the efficacy and safety of chemo-radiotherapy combined with hyperthermia (HCRT) for rectal cancer, and to provide evidence for clinical practice. Methods We searched the Cochrane Library (Issue 6, 2014), PubMed, EMbase, Web of Science, CBM, CNKI, VIP and WanFang Data databases from inception to July 2014. All relevant randomized controlled trials (RCTs) of HCRT for rectal cancer were collected. Two reviewers independently screened literature, extracted data, and assessed the risk of bias of included studies. Then meta-analysis was performed using RevMan 5.3 software. Results A total of 9 RCTs involving 663 patients were included. The results of meta-analysis showed that:Compared with the chemo-radiotherapy (CRT) group, the HCRT group were significant superior in complete response (OR=3.74, 95%CI 2.14 to 6.53), total effective rate (OR=4.23, 95%CI 2.69 to 6.66), 3-year survival rate (OR=4.48, 95%CI 1.81 to 11.06) and recurrence rate (OR=0.19, 95%CI 0.09 to 0.42). ②Compared with the radiotherapy (RT) group, the HCRT group was associated with significant improvement in complete response rate (OR=3.01, 95%CI 1.24 to 7.29). Conclusion Current evidence shows, HCRT is superior to CRT or RT in the treatment of rectal cancer. However, due to the limited quantity and quality of the included studies, more high quality studies are needed to verify the above conclusion.

Citation: LIZheng, MIDeng-hai, YANGKe-hu, CAONong, TIANJin-hui, MABin, BAIZheng-gang. Efficacy and Safety of Hyperthermo-Chemo-Radiotherapy for Rectal Cancer: A Systematic Review. Chinese Journal of Evidence-Based Medicine, 2015, 15(6): 687-692. doi: 10.7507/1672-2531.20150114 Copy

  • Previous Article

    Efficacy and Safety of Enteric-coated Mycophenolate Sodium versus Mycophenolate Mofetil in Renal Transplant Recipients: A Meta-analysis
  • Next Article

    I.V. Infusion of Dezocine before Etomidate Administration for Myoclonus of Prevention Caused by Etomidate: A Systematic Review